J9277
HCPCSPembrolizumab 1mg berahyalur
Official HCPCS Level II long descriptor
Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
HCPCS Level II code J9277 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Pembrolizumab 1mg berahyalur
Added to HCPCS: 2026-04-01
Nearby codes in J9
- J9268Pentostatin injection
- J9269Inj. tagraxofusp-erzs 10 mcg
- J9271Inj pembrolizumab
- J9272Inj, dostarlimab-gxly, 10 mg
- J9273Inj tisotu vedotin-tftv, 1mg
- J9274Inj, tebentafusp-tebn, 1 mcg
- J9275Inj cosibelimab-ipdl, 2 mg
- J9276Inj zanidatamab-hrii, 2 mg
- J9278Inj, carboplatin (avyxa)
- J9280Mitomycin injection
- J9281Mitomycin instillation
- J9282Mitomycin intravesical inst
- J9285Inj, olaratumab, 10 mg
- J9286Inj glofitamab gxbm, 2.5 mg
- J9289Inj nivolumab 2 mg hyaluron
- J9292Inj, pemetrexed dipotassium
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.